157
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Pre-Existing Allergies Patients with Higher Viral Load and Longer Recovery Days Infected by SARS-CoV-2 Omicron BA.2 in Shanghai, China, 2022

, , , , , , ORCID Icon & ORCID Icon show all
Pages 903-913 | Received 13 Jan 2023, Accepted 12 Jun 2023, Published online: 01 Sep 2023

References

  • Available from: https://covid19.who.int/. Accessed July 31, 2023.
  • Hoffmann M, Kruger N, Schulz S, et al. The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic. Cell. 2022;185:447–56 e11.
  • Du H, Dong X, Zhang JJ, et al. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2021;76(2):510–532. doi:10.1111/all.14452
  • Baseggio Conrado A, Ierodiakonou D, Gowland MH, Boyle RJ, Turner PJ. Food anaphylaxis in the United Kingdom: analysis of national data, 1998–2018. BMJ. 2021;372:n251. doi:10.1136/bmj.n251
  • Krishnamoorthy N, Douda DN, Bruggemann TR, et al. Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma. Sci Immunol. 2018;3(26). doi:10.1126/sciimmunol.aao4747
  • Hou X, Luo W, Wu L, et al. Associations of Four sensitization patterns revealed by Latent Class Analysis with Clinical symptoms: a multi-center study of China. EClinicalMedicine. 2022;46:101349.
  • Yang JM, Koh HY, Moon SY, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol. 2020;146(4):790–798. doi:10.1016/j.jaci.2020.08.008
  • Lu L, Mok BW, Chen LL, et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients. Clin Infect Dis. 2021;75(1):e822–e826.
  • Gilles S, Blume C, Wimmer M, et al. Pollen exposure weakens innate defense against respiratory viruses. Allergy. 2020;75(3):576–587. doi:10.1111/all.14047
  • Leino A, Lukkarinen M, Turunen R, et al. Pulmonary function and bronchial reactivity 4 years after the first virus-induced wheezing. Allergy. 2019;74:518–526.
  • Papadopoulos NG, Christodoulou I, Rohde G, et al. Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy. 2011;66(4):458–468. doi:10.1111/j.1398-9995.2010.02505.x
  • Dong X, Cao YY, Lu XX, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020;75(7):1699–1709. doi:10.1111/all.14289
  • Guideline on diagnosis and treatment of COVID-19; 2022. Available from http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88/files/ef09aa4070244620b010951b088b8a27. Accessed July 31, 2023.
  • Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008;27:2037–2049.
  • Kim SY, Yeniova AÖ. Global, regional, and national incidence and mortality of COVID-19 in 237 countries and territories, January 2022: a systematic analysis for World Health Organization COVID-19 Dashboard. Life Cycle. 2022;2. doi:10.54724/lc.2022.e10
  • Kaminsky LW, Dalessio S, Al-Shaikhly T, Al-Sadi R. Penicillin allergy label increases risk of worse clinical outcomes in COVID-19. J Allergy Clin Immunol Pract. 2021;9(10):3629–37.e2. doi:10.1016/j.jaip.2021.06.054
  • Gutierrez-Merino J, Isla B, Combes T, Martinez-Estrada F, Maluquer De Motes C. Beneficial bacteria activate type-I interferon production via the intracellular cytosolic sensors STING and MAVS. Gut Microbes. 2020;11:771–788.
  • Kimura I, Konno Y, Uriu K, et al. Sarbecovirus ORF6 proteins hamper induction of interferon signaling. Cell Rep. 2021;34(13):108916. doi:10.1016/j.celrep.2021.108916
  • Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135(4):956–63 e1. doi:10.1016/j.jaci.2014.10.021
  • Moghimi SM. Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines. Mol Ther. 2021;29(3):898–900. doi:10.1016/j.ymthe.2021.01.030
  • Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE. Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 2016;46:1099–1110.
  • Vezir E, Hizal M, Cura Yayla B, et al. Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection? Allergy Asthma Proc. 2021;42(6):522–529. doi:10.2500/aap.2021.42.210087
  • Singhal T. The Emergence of Omicron: challenging Times Are Here Again! Indian J Pediatr. 2022;89(5):490–496. doi:10.1007/s12098-022-04077-4
  • Yu W, Freeland DMH, Nadeau KC. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol. 2016;16:751–765.
  • Valenta R, Hochwallner H, Linhart B, Pahr S. Food allergies: the basics. Gastroenterology. 2015;148:1120–31.e4.
  • Cianferoni A, Votto M, Marseglia GL. COVID-19 and allergy: how to take care of allergic patients during a pandemic? Pediatr Allergy Immunol. 2020;31(Suppl 26):96–101. doi:10.1111/pai.13367
  • Rose M, Trubiano J. Assessing low-risk penicillin allergies in critical COVID-19, a novel perspective on an emerging antibiotic allergy opportunity. J Allergy Clin Immunol Pract. 2023;11(2):636–637. doi:10.1016/j.jaip.2022.11.048
  • Pérez-Encinas M, Lorenzo-Martínez S, Losa-García JE, Walter S, Tejedor-Alonso MA. Impact of penicillin allergy label on length of stay and mortality in hospitalized patients through a clinical administrative national dataset. Int Arch Allergy Immunol. 2022;183:498–506.
  • Sacco KA, Bates A, Brigham TJ, Imam JS, Burton MC. Clinical outcomes following inpatient penicillin allergy testing: a systematic review and meta-analysis. Allergy. 2017;72(9):1288–1296. doi:10.1111/all.13168
  • Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GYH, Kretzschmar MEE. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis. PLoS Med. 2020;17(9):e1003321. doi:10.1371/journal.pmed.1003321
  • Sieswerda E, de Boer MGJ, Bonten MMJ, et al. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Clin Microbiol Infect. 2021;27:61–66.